Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Analysis of long-term survivors with cardiac AL amyloidosis].
Kagawa K, Maeda Y, Oura M, Sogabe K, Fujino H, Takahashi M, Maruhashi T, Iwasa M, Udaka K, Harada T, Ise T, Fujii S, Nakamura S, Miki H, Yagi S, Takeuchi K, Ozaki S, Abe M. Kagawa K, et al. Among authors: oura m. Rinsho Ketsueki. 2017;58(11):2197-2204. doi: 10.11406/rinketsu.58.2197. Rinsho Ketsueki. 2017. PMID: 29212969 Japanese.
Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activity.
Fujii S, Nakamura S, Oda A, Miki H, Tenshin H, Teramachi J, Hiasa M, Bat-Erdene A, Maeda Y, Oura M, Takahashi M, Iwasa M, Endo I, Yoshida S, Aihara KI, Kurahashi K, Harada T, Kagawa K, Nakao M, Sano S, Abe M. Fujii S, et al. Among authors: oura m. Br J Haematol. 2018 Jan;180(2):246-258. doi: 10.1111/bjh.15033. Br J Haematol. 2018. PMID: 29327347 Free article.
Effective impairment of myeloma cells and their progenitors by hyperthermia.
Miki H, Nakamura S, Oda A, Tenshin H, Teramachi J, Hiasa M, Bat-Erdene A, Maeda Y, Oura M, Takahashi M, Iwasa M, Harada T, Fujii S, Kurahashi K, Yoshida S, Kagawa K, Endo I, Aihara K, Ikuo M, Itoh K, Hayashi K, Nakamura M, Abe M. Miki H, et al. Among authors: oura m. Oncotarget. 2017 Dec 7;9(12):10307-10316. doi: 10.18632/oncotarget.23121. eCollection 2018 Feb 13. Oncotarget. 2017. PMID: 29535808 Free PMC article.
Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon-α and ATRA.
Bat-Erdene A, Nakamura S, Oda A, Iwasa M, Teramachi J, Ashtar M, Harada T, Miki H, Tenshin H, Hiasa M, Fujii S, Sogabe K, Oura M, Udaka K, Kagawa K, Yoshida S, Aihara KI, Kurahashi K, Endo I, Abe M. Bat-Erdene A, et al. Among authors: oura m. Br J Haematol. 2019 Jun;185(5):969-974. doi: 10.1111/bjh.15673. Epub 2018 Nov 26. Br J Haematol. 2019. PMID: 30474853 Free article. No abstract available.
Correlation between high serum alkaline phosphatase levels and denosumab-related hypocalcemia in patients with multiple myeloma.
Miki H, Nakamura S, Oura M, Hamano H, Ikuta K, Okada N, Okamoto Y, Sogabe K, Takahashi M, Iwasa M, Udaka K, Harada T, Kurahashi K, Fujii S, Yoshida S, Kagawa K, Endo I, Aihara KI, Abe M. Miki H, et al. Among authors: oura m. Br J Haematol. 2019 Jul;186(2):355-358. doi: 10.1111/bjh.15837. Epub 2019 Mar 11. Br J Haematol. 2019. PMID: 30859556 Free article. Clinical Trial. No abstract available.
PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-γ.
Iwasa M, Harada T, Oda A, Bat-Erdene A, Teramachi J, Tenshin H, Ashtar M, Oura M, Sogabe K, Udaka K, Fujii S, Nakamura S, Miki H, Kagawa K, Ozaki S, Abe M. Iwasa M, et al. Among authors: oura m. Oncotarget. 2019 Mar 8;10(20):1903-1917. doi: 10.18632/oncotarget.26726. eCollection 2019 Mar 8. Oncotarget. 2019. PMID: 30956773 Free PMC article.
TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma.
Teramachi J, Tenshin H, Hiasa M, Oda A, Bat-Erdene A, Harada T, Nakamura S, Ashtar M, Shimizu S, Iwasa M, Sogabe K, Oura M, Fujii S, Kagawa K, Miki H, Endo I, Haneji T, Matsumoto T, Abe M. Teramachi J, et al. Among authors: oura m. Haematologica. 2021 May 1;106(5):1401-1413. doi: 10.3324/haematol.2019.234476. Haematologica. 2021. PMID: 32273474 Free PMC article.
The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat.
Ashtar M, Tenshin H, Teramachi J, Bat-Erdene A, Hiasa M, Oda A, Tanimoto K, Shimizu S, Higa Y, Harada T, Oura M, Sogabe K, Nakamura S, Fujii S, Sumitani R, Miki H, Udaka K, Takahashi M, Kagawa K, Endo I, Tanaka E, Matsumoto T, Abe M. Ashtar M, et al. Among authors: oura m. Cancers (Basel). 2020 Apr 9;12(4):929. doi: 10.3390/cancers12040929. Cancers (Basel). 2020. PMID: 32283857 Free PMC article.
Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma.
Watanabe K, Bat-Erdene A, Tenshin H, Cui Q, Teramachi J, Hiasa M, Oda A, Harada T, Miki H, Sogabe K, Oura M, Sumitani R, Mitsui Y, Endo I, Tanaka E, Kawatani M, Osada H, Matsumoto T, Abe M. Watanabe K, et al. Among authors: oura m. Haematologica. 2021 Apr 1;106(4):1172-1177. doi: 10.3324/haematol.2019.244418. Haematologica. 2021. PMID: 32586903 Free PMC article. No abstract available.
117 results